Nanomedicines (eBook, PDF)

Design, Delivery and Detection
Redaktion: Braddock, Martin

• Format: PDF

Produktbeschreibung

Nanomedicines and nanopharmacology is a rapidly developing and evolving field with new techniques and applications under constant development. This book will provide an overview of the chemistry of nanocarrier design and the considerations that need to be made when developing a nanomedicine. Providing an understanding of the relationship of nanocarrier, drug and targetting moieties and physico-chemical properties, this title will provide an accurate and current representation of the field by addressing the promises, prospects and pitfalls of nanomedicine. Covering a wide range of areas in detail, this book will provide an excellent companion for medicinal chemists, pharmacologists and biochemists working in industry or academia.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, D ausgeliefert werden.

Produktdetails

• Verlag: RSC
• Seitenzahl: 370
• Erscheinungstermin: 14. April 2016
• Englisch
• ISBN-13: 9781782622536
• Artikelnr.: 56996213

Inhaltsangabe

Design Considerations for Properties of Nanocarriers on the Disposition and
Efficiency of Drug and Gene Delivery; Targeting Cyclins and
Cyclin-Dependent Kinases Involved in Cell Cycle Regulation by RNAi as a
Potential Cancer Therapy; Nanoparticle carriers to overcome biological
barriers to siRNA delivery; Magnetic targeting as a vehicle for delivery of
nanomedicines; Development of Theranostics - Imaging Considerations and
Targeted Drug Delivery; The Role of Imaging in Nanomedicine Development and
Clinical Translation; Anticancer agent-incorporating polymeric micelles:
from bench to bedside; Polymeric Nanoparticles and Cancer: Lessons Learnt
from CRLX101; Nanodelivery Strategies in Breast Cancer Chemotherapy;
Developing a Predictable Regulatory Path for Nanomedicines by Accurate and
Objective Particle Measurement; Nanomedicine: Promises and Challenges; The
Challenge of Regulating Nanomedicine: Key Issues; Doxil® - The First
FDA-Approved Nano-Drug: From Basics via CMC, Cell Culture and Animal
Studies to Clinical Use